Profiel
Mark Novotny currently works at CardioMech AS, as Chairman and Spinal Stabilization Technologies LLC, as President & Director.
Actieve functies van Mark Novotny
| Bedrijven | Functie | Begin |
|---|---|---|
Spinal Stabilization Technologies LLC
 Spinal Stabilization Technologies LLC Medical SpecialtiesHealth Technology Spinal Stabilization Technologies LLC designs, develops, and manufactures spinal medical devices that meet or exceed the expectations of our patients, customers, and regulatory agencies; and to maintain and improve the effectiveness of our quality management system. The company was founded in 2010 and is headquartered in San Antonio, TX. | President | - |
CardioMech AS
 CardioMech AS Medical SpecialtiesHealth Technology Cardiomech AS develops the next generation of interventional devices for structural heart disease. It provides transfemoral transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve. The company was founded by Nikolai Hiorth and Jacob Bergsland and is headquartered in Trondheim, Norway. | Voorzitter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Spinal Stabilization Technologies LLC
Spinal Stabilization Technologies LLC Medical SpecialtiesHealth Technology Spinal Stabilization Technologies LLC designs, develops, and manufactures spinal medical devices that meet or exceed the expectations of our patients, customers, and regulatory agencies; and to maintain and improve the effectiveness of our quality management system. The company was founded in 2010 and is headquartered in San Antonio, TX. | Health Technology |
CardioMech AS
CardioMech AS Medical SpecialtiesHealth Technology Cardiomech AS develops the next generation of interventional devices for structural heart disease. It provides transfemoral transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve. The company was founded by Nikolai Hiorth and Jacob Bergsland and is headquartered in Trondheim, Norway. | Health Technology |
